Related Articles
CDK4/6 inhibitor resistance mechanisms and treatment strategies (Review)
Severe hypoglycaemia under abemaciclib administration in a patient with breast cancer: A case report
Novel treatment strategies for patients with HER2‑positive breast cancer who do not benefit from current targeted therapy drugs (Review)
High vascular endothelial growth factor gene expression predicts poor outcome in patients with non-luminal A breast cancer
Apatinib combined with trastuzumab and albumin‑bound paclitaxel for treatment of HER2+ breast cancer with brain metastases resistant to anti‑HER2 TKIs: A case report